Sodium zirconium cyclosilicate for the management of hyperkalaemia in patients with heart failure with reduced ejection fraction - the REALIZE-K open-label run-in phase
17 May 2025 (08:00 - 12:45)
Organised by: 

About the speaker

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor E. Rodenas Alesina (Barcelona, ES)
Doctor P. Tolomeo (Glasgow, GB)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
You may be interested in
Congress Presentation

